Article Information
History
- August 13, 2020.
Article Versions
- Version 1 (July 14, 2020 - 04:21).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hitoshi Dejima1,17,
- Xin Hu2,17,
- Runzhe Chen3,17,
- Jiexin Zhang4,17,
- Junya Fujimoto1,17,
- Edwin R. Parra1,
- Cara Haymaker1,
- Shawna Hubert3,
- Dzifa Duose1,
- Luisa M. Solis1,
- Dan Su5,6,
- Junya Fukuoka7,
- Kazuhiro Tabata7,
- Hoa Pharm7,
- Nicholas Mcgranahan8,
- Baili Zhang1,
- Jie Ye3,
- Lisha Ying5,9,
- Latasha Little2,
- Curtis Gumbs2,
- Chi-Wan Chow1,
- Marcos Roberto Estecio10,11,
- Myrna C.B. Godoy12,
- Mara B. Antonoff13,
- Boris Sepesi13,
- Harvey Pass14,
- Carmen Behrens3,
- Jianhua Zhang2,
- Ara A. Vaporciyan13,
- John V. Heymach3,
- Paul Scheet15,
- J. Jack Lee16,
- P. Andrew Futreal2,
- Alexandre Reuben3,*,
- Humam Kadara1,*,
- Ignacio Wistuba1,* and
- Jianjun Zhang2,3,18,*
- 1Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 2Departments of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 3Departments of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 4Departments of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 5Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China
- 6Department of Pathology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China
- 7Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
- 8Cancer Research United Kingdom-University College London Lung Cancer Centre of Excellence, London, UK
- 9Zhejiang Cancer Research Institute, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China
- 10Departments of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 11Departments of Center of Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 12Departments of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 13Departments of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 14Department of Cardiothoracic Surgery, New York University Langone Medical Center, New York, NY 10016, USA
- 15Departments of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 16Departments of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- ↵*Correspondence: AReuben{at}mdanderson.org (A.R), HKadara{at}mdanderson.org (H.K.), Iiwistuba{at}mdanderson.org (I.W.), Jzhang20{at}mdanderson.org (J.Z.)
↵17 These authors contributed equally
18 Lead Contact
Posted August 13, 2020.
Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features
